Citadel Advisors - BCLS ACQUISITION CORP ownership

BCLS ACQUISITION CORP's ticker is BLSA and the CUSIP is G0904B105. A total of 47 filers reported holding BCLS ACQUISITION CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of BCLS ACQUISITION CORP
ValueSharesWeighting
Q3 2022$6,904,000
+1.2%
689,015
+0.0%
0.00%0.0%
Q2 2022$6,821,000
+0.3%
688,9400.0%0.00%
+100.0%
Q1 2022$6,800,000
+0.1%
688,9400.0%0.00%0.0%
Q4 2021$6,793,000
-1.8%
688,940
-0.4%
0.00%0.0%
Q3 2021$6,915,000
-4.7%
691,490
+0.4%
0.00%
-50.0%
Q2 2021$7,255,000
-6.3%
688,940
-5.9%
0.00%0.0%
Q1 2021$7,741,000
-4.3%
732,377
-0.2%
0.00%0.0%
Q4 2020$8,086,000733,4950.00%
Other shareholders
BCLS ACQUISITION CORP shareholders Q4 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 843,122$8,912,0003.21%
COMMODORE CAPITAL LP 250,000$2,643,0001.05%
Samsara BioCapital, LLC 300,000$3,171,0000.58%
SPHERA FUNDS MANAGEMENT LTD. 687,900$7,271,0000.56%
Asymmetry Capital Management, L.P. 82,377$871,0000.45%
First Trust Capital Management L.P. 191,272$2,022,0000.40%
Altium Capital Management LP 100,000$1,057,0000.29%
Bain Capital Life Sciences Investors, LLC 487,500$5,153,0000.29%
RA Capital Management 1,250,000$13,213,0000.20%
Boxer Capital, LLC 500,000$5,285,0000.18%
View complete list of BCLS ACQUISITION CORP shareholders